|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Nagini S: Carcinoma of the stomach: a
review of epidemiology, pathogenesis, molecular genetics and
chemoprevention. World J Gastrointest Oncol. 4:156–169. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Danaei G, Vander Hoorn S, Lopez AD, Murray
CJ and Ezzati M; Comparative Risk Assessment collaborating group
(cancers). Causes of cancer in the world: comparative risk
assessment of nine behavioural and environmental risk factors.
Lancet. 366:1784–1793. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Catalano V, Labianca R, Beretta GD, Gatta
G, de Braud F and Van Cutsem E: Gastric cancer. Crit Rev Oncol
Hematol. 71:127–164. 2009. View Article : Google Scholar
|
|
5
|
Przybyło M, Pocheć E, Link-Lenczowski P
and Lityńska A: Beta 1–6 branching of cell surface glycoproteins
may contribute to uveal melanoma progression by up-regulating cell
motility. Mol Vis. 14:625–636. 2008.
|
|
6
|
Murata K, Miyoshi E, Kameyama M, et al:
Expression of N-acetylglucosaminyltransferase V in colorectal
cancer correlates with metastasis and poor prognosis. Clin Cancer
Res. 6:1772–1777. 2000.PubMed/NCBI
|
|
7
|
Guo P, Chen HJ, Wang QY and Chen HL:
Downregulation of N-acetylglucosaminyltransferase V facilitates
all-trans retinoic acid to induce apoptosis of human
hepatocarcinoma cells. Mol Cell Biochem. 284:103–110.
2005.PubMed/NCBI
|
|
8
|
Xu YY, Lu Y, Fan KY and Shen ZH: Apoptosis
induced by all-trans retinoic acid in
N-acetylglucosaminyltransferase V repressed human hepatocarcinoma
cells is mediated through endoplasmic reticulum stress. J Cell
Biochem. 100:773–782. 2007.
|
|
9
|
Dosaka-Akita H, Miyoshi E, Suzuki O, Itoh
T, Katoh H and Taniguchi N: Expression of
N-acetylglucosaminyltransferase V is associated with prognosis and
histology in non-small cell lung cancers. Clin Cancer Res.
10:1773–1779. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ishimura H, Takahashi T, Nakagawa H, et
al: N-acetylglucsaminyltransferase V and beta1–6 branching N-linked
oligosaccharides are associated with good prognosis of patients
with bladder cancer. Clin Cancer Res. 12:2506–2511. 2006.
|
|
11
|
Inamori K, Gu J, Ohira M, et al: High
expression of N-acetylglucosaminyltransferase V in favorable
neuroblastomas: involvement of its effect on apoptosis. FEBS Lett.
580:627–632. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tian H, Miyoshi E, Kawaguchi N, et al: The
implication of N-acetylglucosaminyltransferase V expression in
gastric cancer. Pathobiology. 75:288–294. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hsieh CY, Tsai PC, Tseng CH, Chen YL,
Chang LS and Lin SR: Inhibition of EGF/EGFR activation with
naphtho(1,2-b)furan-4,5-dione blocks migration and invasion of
MDA-MB-231 cells. Toxicol In Vitro. 27:1–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baselga J and Arteaga CL: Critical update
and emerging trends in epidermal growth factor receptor targeting
in cancer. J Clin Oncol. 23:2445–2459. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rothhut B, Ghoneim C, Antonicelli F and
Soula-Rothhut M: Epidermal growth factor stimulates matrix
metalloproteinase-9 expression and invasion in human follicular
thyroid carcinoma cells through focal adhesion kinase. Biochimie.
89:613–624. 2007. View Article : Google Scholar
|
|
16
|
Mascia F, Cataisson C, Lee TC, et al: EGFR
regulates the expression of keratinocyte-derived
granulocyte/macrophage colony-stimulating factor in vitro and in
vivo. J Invest Dermatol. 130:682–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pastore S, Mascia F, Mariani V and
Girolomoni G: The epidermal growth factor receptor system in skin
repair and inflammation. J Invest Dermatol. 128:1365–1374. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pastore S and Mascia F: Novel acquisitions
on the immunoprotective roles of the EGF receptor in the skin.
Expert Rev Dermatol. 3:525–527. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kimura A, Terao M, Kato A, et al:
Upregulation of N-acetylglucosaminyltransferase-V by
heparin-binding EGF-like growth factor induces keratinocyte
proliferation and epidermal hyperplasia. Exp Dermatol. 21:515–519.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao Y, Sato Y, Isaji T, et al: Branched
N-glycans regulate the biological functions of integrins and
cadherins. FEBS J. 275:1939–1948. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gu J, Zhao Y, Isaji T, et al:
Beta1,4-N-acetylglucosaminyltransferase III down-regulates neurite
outgrowth induced by costimulation of epidermal growth factor and
integrins through the Ras/ERK signaling pathway in PC12 cells.
Glycobiology. 14:177–186. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao Y, Nakagawa T, Itoh S, et al:
N-acetylglucosaminyl transferase III antagonizes the effect of
N-acetylglucosaminyl transferase V on α3β1 integrin-mediated cell
migration. J Biol Chem. 281:32122–32130. 2006.
|
|
23
|
Chavez MG, Buhr CA, Petrie WK,
Wandinger-Ness A, Kusewitt DF and Hudson LG: Differential
downregulation of E-cadherin and desmoglein by epidermal growth
factor. Dermatol Res Pract. 2012:3095872012.PubMed/NCBI
|
|
24
|
Terao M, Ishikawa A, Nakahara S, et al:
Enhanced epithelial-mesenchymal transition-like phenotype in
N-acetylglucosaminyltransferase V transgenic mouse skin promotes
wound healing. J Biol Chem. 286:28303–28311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dilly M, Hambruch N, Haeger JD and Pfarrer
C: Epidermal growth factor (EGF) induces motility and upregulates
MMP-9 and TIMP-1 in bovine trophoblast cells. Mol Reprod Dev.
77:622–629. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Delassus GS, Cho H, Park J and Eliceiri
GL: New pathway links from cancer-progression determinants to gene
expression of matrix metalloproteinases in breast cancer cells. J
Cell Physiol. 217:739–744. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fink K and Boratyński J: The role of
metalloproteinases in modification of extracellular matrix in
invasive tumor growth, metastasis and angiogenesis. Postepy Hig Med
Dosw (Online). 66:609–628. 2012.(In Polish).
|
|
29
|
Partridge JJ, Madsen MA, Ardi VC,
Papagiannakopoulos T, Kupriyanova TA, Quigley JP and Deryugina EI:
Functional analysis of matrix metalloproteinases and tissue
inhibitors of metalloproteinases differentially expressed by
variants of human HT-1080 fibrosarcoma exhibiting high and low
levels of intravasation and metastasis. J Biol Chem.
282:35964–35977. 2007. View Article : Google Scholar
|
|
30
|
Di Carlo A: Matrix metalloproteinase-2 and
-9 in the sera and in the urine of human oncocytoma and renal cell
carcinoma. Oncol Rep. 28:1051–1056. 2012.PubMed/NCBI
|
|
31
|
Zhuo E, He J, Wei T, et al:
Down-regulation of GnT-V enhances nasopharyngeal carcinoma cell
CNE-2 radiosensitivity in vitro and in vivo. Biochem Biophys Res
Commun. 424:554–562. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Beheshti Zavareh R, Sukhai MA, Hurren R,
et al: Suppression of cancer progression by MGAT1 shRNA knockdown.
PLoS One. 7:e437212012.PubMed/NCBI
|
|
33
|
Xu Q, Isaji T, Lu Y, et al: Roles of
N-acetylglucosaminyltrans-ferase III in epithelial-to-mesenchymal
transition induced by transforming growth factor β1 (TGF-β1) in
epithelial cell lines. J Biol Chem. 287:16563–16574.
2012.PubMed/NCBI
|
|
34
|
Li D, Li Y, Wu X, et al: Knockdown of
Mgat5 inhibits breast cancer cell growth with activation of
CD4+ T cells and macrophages. J Immunol. 180:3158–3165.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pinho SS, Reis CA, Paredes J, et al: The
role of N-acetylglucosaminyltransferase III and V in the
post-transcriptional modifications of E-cadherin. Hum Mol Genet.
18:2599–2608. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pinho SS, Seruca R, Gärtner F, Yamaguchi
Y, Gu J, Taniguchi N and Reis CA: Modulation of E-cadherin function
and dysfunction by N-glycosylation. Cell Mol Life Sci.
68:1011–1020. 2011.PubMed/NCBI
|
|
37
|
Zhao H, Liang Y, Xu Z, et al:
N-glycosylation affects the adhesive function of E-Cadherin through
modifying the composition of adherens junctions (AJs) in human
breast carcinoma cell line MDA-MB-435. J Cell Biochem. 104:162–175.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu T, Zhang X, Shang M, et al:
Dysregulated expression of Slug, vimentin, and E-cadherin
correlates with poor clinical outcome in patients with basal-like
breast cancer. J Surg Oncol. 107:188–194. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Roberti MP, Arriaga JM, Bianchini M, et
al: Protein expression changes during human triple negative breast
cancer cell line progression to lymph node metastasis in a
xenografted model in nude mice. Cancer Biol Ther. 13:1123–1140.
2012. View Article : Google Scholar : PubMed/NCBI
|
